This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

If its any crumb of comfort, even from 70p, at times last year I sat on 25-30% paper losses but eventually got my reward. MMG could and should still reward if you can afford to be patient and hold, depends on individual circumstances.
Good Luck to all MMG holders, whatever you decide BUT if anyone does sell out for now, keep on your watchlist and pick a moment to get back in. Imagine what will happen to the sp when there is THE news everyone has been waiting for.

Baza, the only secret was having held MMG for over a year I couldn't see IMO how the extra Genvax news made it rise from 70pish on Jan 3rd to 300p. And no I'm not a shorter, it just felt too high and driven on the crest of hype surrounding possible Ruthenium trials in the Spring, although I must admit in the last few weeks to thinking that I'd missed the opportunity when I've dallied around wondering whether or not to get back in . Why didn't I buy again? as I said on this board a few weeks ago, several times MMG has flattered to deceive on its timing only, expectation grows, so does the sp and then there is no news or delays and it falls and you are left holding a paper loss until the next good news or publicity. Having sold at 270p, if the presentation had detailed early next stage trialing I had time even on the day to get back in at a lower price, as it was there was no real immediate news and it goes back to 170p. Yes, it looks like in the end I made a good call, about bloody time cos I get more wrong than right but hopefully I'm learning and making fewer mistakes and more good calls. MMG will remain on my watchlist, it should see 300p again in 2005 if the plan hits its targets and Ruthenium does progress to clinical trials.

cheers GF.

So what do we put the present price drop down to then.What has changed over the last month?
Well......A lot of shorters taking advantage of the rise in sp is obviously the main one and so what,does it really matter?It does if you want a quick profit but in the long term you will hopefully be rewarded in both money and maybe a cure for your illness now or in the future.
Maybe BB's are powerfull after all!The drop in price if you graphed it up to worth while inputs on BB's would be very interesting I think.I can understand why the sp has dropped so far due to the trials ongoing,so no cure yet,but the feed back from the company is still very good!Would expect the sp to drift around(by a big margin)the 190 mark until more positive news is released.
My father was diagnosed with prostate cancer about 4 years ago and the three choices he had to make to make him live longer with any sort of life were quite frightening.One of the choices was to have some radiation treatment with a certain % of success but if it didn't work they wouldn't be able to do any more for him,once you had this treatment you couldn't do anything else!!!Can't remember the second choice but he chose the third which i think was to rip the problem out,he has a normal life now but still gets regular checks.
If anyone would like the three choices explained in more detail i will ask him and post his answers.
The above is related to another field of mmg,and not the main one we are looking forward for results in.
Anyway I bought a few more today.....it's heredatary(might not be spelt right-lol)so have a personal interest!

PS I would gladly miss a couple of grand just for the chance of a cure or even a stabilising drug.Still very early days but here's hoping.
Must admit i didn't realise the extent of this companies portfolio when i bought in 2 years ago and lost faith summer of last year.Then bought back in october time but needed some cash,think it was feb at 90p.Back in now at 250 and 174 with a view of selling up on my other shares and putting all me eggs in one basket.Very foolish you might say....but as i've said before i have an interest health wise so i'd rather invest and take a so called paper loss short term.God it sounds like a ramp,non intended as i'm sure the sp will fall short term.

The fall out from the presentation is starting to hurt. I won't get caught like this again.

MS

I don't think its just because of that Mickey,all the shares i hold, or that are on my watch list are taking a battering,look at NLR..JB..

Ive sent Best an e-mail Mickey telling him just how I felt about his presentation and how I felt that he had shot himself in the foot. When and if I get a reply I will post it.

The best thing with these though is that on any good news they do ride up quickly and we should get plenty of it during the year.

cheers GF.

A sea of red out there again, total carnage, this is getting serious. MMs as usual over doing the falls on prices, its about time their practices were investigated. Just look at how they have marked Hamworthy down, but yet when people are buying it takes all day to get a miserly penny or two increase, were being robbed. Investors will be moving into bonds and so will I if we get much more of this.

cheers GF.

How do bonds work GF

I agree GF. I just don't know how the MMs are allowed to get away with it. The FSA are a load of wankers so we're on our own and at the mercy of the MMs.

GF

Another down day again today just hoping that when the Ru news is finally out that it reverses its position...bought yesterday and will see what happens to the Market in general before adding again..

OK lets keep positive. Read this from the other side and lets all be patient and see what the future holds.

osull - 29 Apr'05 - 09:41 - 5395 of 5395


As has been said, this current drop in sp seems to be savage punishment for lack of hard news coming out of the R&D presentation. But by any reasonable criteria the current sp must represent a fraction of MMG's true value.

For what it's worth, try doing this:
-calculate a product's royalty income over the life of its patent
-discount this income back to its present value
-multiply the PV of future income by the probability of the product successfully reaching the market
Now do this for each of MMG's products, and add the results together.
What do you get?

When calculating the probability that the portfolio of ruthenium products is a success, don't forget to factor in that Dr James Hoeschele, the inventor of Carboplatin, has been persuaded to join the MMG team. By that I mean that, presumably, he thinks that the ruthenium products stand a good enough chance of success to be worth him investing his time.

And, finally, did I read somewhere that Insinger has brought out a new note putting a value of 2.75 on MMG share price?

MS

Hi GF

I totally agree with you. We seem to see major drops every day followed by insignificant (if any) rises and major MM influence.

Personally, I know a lot of day traders who are spread betting the indices at the moment. The DOW for instance has been moving 70 points plus regularly and is very volatile during the day. There are no dealing fees and the MM's influence is watered down to some extent. You can easily short it, which is very attractive currently, and reverse your positions regularly. It's just the environment for those who want to make (and probably lose) a quick buck.

All in all, I think that those left are the longer term investors who take a genuine interest in the company they invest in and like the thrill of the chase regarding the research they do. That's not a bad thing to me, as the more knowledgeable the contributors to a thread are, the less susceptible new investor like myself are to hype, rampers, derampers, etc.

Good luck to everyone who holds (as I do at 178p). Patience is a virtue which I think will be rewarded with MMG as the company is well run and seems to have good products in development and a bright future. Doesn't seem that bad an investment to me.

Regards.

Mark.

Well said Mark.

MS

Barry it depends what type of Bonds you want to invest in. If you go over to the Ample board or the Motley Fool Board there are sections there that go into great detail.

I agree with you guys on what as been said over the last few posts. Its time we got a governing body that had retail investors affairs at heart. The FSA just look after the big institutions, they are useless.

Anyway Im going back to bed. Pointless investing in this market as it stands. Every day we think we have hit the bottom only to find we drop further down the day after. Newbies to the stock market will be lost for ever, I feel sorry for them.


cheers GF.

cheers GF.

Thanks Mickey ~ please keep posting as I really enjoy what you write and find your work really informative.

GF ~ couldn't agree with you more about the FSA. I have worked in the financial services industry for 18 years and have had many meetings/compliance visits from them and their predecessors. In summary, they have not got a clue about real work regulation and simply add so much documentation to a deal, that the customers are actually less informed than they ever have been as they can't possibly take in all the detail on 50+ pages of recommendations from a broker. A real waste of time.

On a separate note, keep your chin up mate and don't get too down about the current market. It's not bad, it's just a great learning process. After all, there are only good times and times when we learn, and what do we really learn during the good times?

Good luck to all.

Mark.

Some good posts from you know where. Keep the faith and keep your shares.

osull - 29 Apr'05 - 10:54 - 5397 of 5400


Campelltown,

"whatever it CAN be worth isn't what it is worth now"

Quite right. However, investors need to have some basis for deciding whether to hold or sell or buy right now. Calculating share price based on expected values has the advantage of taking both possible outcomes, sucess and failure of a product, into account.

"at present its what you will pay for the probability of success"

Of course, there is a significant element of subjectivity in these calculations, but, it seems to me, that even the most pessimistic set of assumptions creates a market cap far above what the market currently has for MMG.

A0469514 - 29 Apr'05 - 10:59 - 5398 of 5400


Good posts osull.

And what was the problem with the presentation, apart from the sound quality, which was unfortunate, but down to Buchanan.

I learnt a lot about what is going on and felt very reasured by it.
In particular, I was pretty convinced by the presentation that ruthenium has a strong probability of being a future blockbuster. If, as seems very possible, it has potential worldwide sales of $5 billion plus a year, big pharma will be ready to do a very big deal for that when the time is right. Do not forget, this company has only 12 employees. One big deal and their fortune is made. The sceptics will say, well when they do the deal, then I will invest and sure, you may make a few quid. But the big money will be made by investors who get in early.

The other big news in the presentation was that the Genvax prostate trial has already started. If that works, and it seems the similar lymphoma trial certainly does, then they are onto another potential blockbuster. Prostate cancer, as many know on here, is a common and very nasty problem that, so far as I am aware, has no successful drug to combat it. It is already in phase IIa trials.

So it is quite possible, as I see it, that the guys at MMG could make their fortunes twice over, and not have to wait too long either. I intend to hang on to their coat-tails and bought a few more yesterday. Long term, I feel very confident despite the generally depressed mood in the markets.

Xylos.

MS

Banjomick,your reason for holding MMG is excellent, I continue to hold MDW for much the same reason despite the current low sp. MMG is doing fantastic research in a number of areas that should benefit us all.
Markp, great comment about learning, its true, you learn the most when it goes against you, the sp of MMG has temporarily gone against holders but another excellent comment by gf, it will fly the other way when news is announced.
What to do in the meantime? Several calls can be made but which one is best who knows, MMG definitely retained on my watchlist with a target to BUY again.

From the other place. Says it all really. Have a good one people and don't get too pissed.

A0469514 - 29 Apr'05 - 15:10 - 5405 of 5405


ecoejh, You made an enquiry this morning when people were feeling a bit depressed. What have they got on the go? Well, if you have been back, you may have picked up a few things but I think I can sumarise for you.

1. They will have 10 drugs in clinical trials next year. More than most other companies.

2. It looks possible that at least 2 of these may turn out to be huge earners for the company helping to cure different cancers.

3. They have a very promising pipeline coming through being researched by some of the top universities and teaching hospitals.

4. Their burn rate (running costs) is the lowest in the sector. They have only 12 employees.

That, if things work out right, is a pretty unbeatable package. If they score with just one of their candidates, the share price does not remotely reflect the potential earnings. That is why it is my biggest holding.

Xylos

LOL

MS